Page 280 - Williams Hematology ( PDFDrive )

254 Part IV: Molecular and Cellular Hematology Chapter 17: Signal Transduction Pathways 255

73. White MF: The IRS-1 signaling system. Curr Opin Genet Dev 4:47, 1994. 99. Otipoby KL, Draves KE, Clark EA: CD22 regulates B cell receptor-mediated signals via
74. Gu H, Neel BG: The “Gab” in signal transduction. Trends Cell Biol 13:122, 2003. two domains that independently recruit Grb2 and SHP-1. J Biol Chem 276:44315, 2001.
75. Micheau O, Tschopp J: Induction of TNF receptor I-mediated apoptosis via two 100. Pani G, Fischer KD, Mlinaric-Rascan I, et al: Signaling capacity of the T cell antigen
sequential signaling complexes. Cell 114:181, 2003. receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med 184:839,
76. Cantor AB, Orkin SH: Hematopoietic development: A balancing act. Curr Opin Genet 1996.
Dev 11:513, 2001. 101. Binstadt BA, Brumbaugh KM, Dick CJ, et al: Sequential involvement of Lck and SHP-1
77. Liu KD, Gaffen SL, Goldsmith MA, et al: Janus kinases in interleukin-2-mediated sig- with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase
naling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation. Curr activation. Immunity 5:629, 1996.
Biol 7:817, 1997. 102. Kim CH, Qu CK, Hangoc G, et al: Abnormal chemokine-induced responses of imma-
78. Wakao H, Harada N, Kitamura T, et al: Interleukin 2 and erythropoietin activate ture and mature hematopoietic cells from motheaten mice implicate the protein
STAT5/MGF via distinct pathways. EMBO J 14:2527, 1995. tyrosine phosphatase SHP-1 in chemokine responses. J Exp Med 190:681, 1999.
79. Drachman JG, Sabath DF, Fox NE, et al: Thrombopoietin signal transduction in puri- 103. Sharlow ER, Pacifici R, Crouse J, et al: Hematopoietic cell phosphatase negatively regu-
fied murine megakaryocytes. Blood 89:483, 1997. lates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells. Blood
80. Kapur R, Cooper R, Zhang L, et al: Cross-talk between alpha(4)beta(1)/alpha(5)beta(1) 90:2175, 1997.
and c-Kit results in opposing effect on growth and survival of hematopoietic cells via 104. Longmore GD: Erythropoietin receptor mutations and Olympic glory. Nat Genet 4:108,
the activation of focal adhesion kinase, mitogen-activated protein kinase, and Akt sig- 1993.
naling pathways. Blood 97:1975, 2001. 105. Yoshimura A, Ohkubo T, Kiguchi T, et al: A novel cytokine-inducible gene CIS encodes
81. Fox N, Kaushansky K: Engagement of integrin alpha 4 beta 1 but not alpha 5 beta an SH2-containing protein that binds to tyrosine phosphorylated interleukin 3 and ery-
1 enhances thrombopoietin (TPO)-induced megakaryocyte (MK) growth. Blood thropoietin receptors. EMBO J 14:2816, 1995.
98:292a, 2001. 106. Naka T, Narazaki M, Hirata M, et al: Structure and function of a new STAT-induced
82. Habib T, Nelson A, Kaushansky K: IL-21: A novel IL-2-family lymphokine that modu- STAT inhibitor. Nature 387:924, 1997.
lates B, T, and natural killer cell responses. J Allergy Clin Immunol 112:1033, 2003. 107. Starr R, Willson TA, Viney EM, et al: A family of cytokine-inducible inhibitors of sig-
83. Bacon CM, Petricoin EF 3rd, Ortaldo JR, et al: Interleukin 12 induces tyrosine phos- nalling. Nature 387:917, 1997.
phorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A 108. Wormald S, Hilton DJ: Inhibitors of cytokine signal transduction. J Biol Chem 279:821,
92:7307, 1995. 2004.
84. Chen E, Beer PA, Godfrey AL, et al: Distinct clinical phenotypes associated with 109. Inagaki-Ohara K, Kondo T, Ito M, Yoshimura A. SOCS, inflammation, and cancer. JAK-
JAK2V617F reflect differential STAT1 signaling. Cancer Cell 18:524, 2010. STAT 2:e24053, 2013.
85. Jones RB, Gordus A, Krall JA, MacBeath G: A quantitative protein interaction network 110. Grimm OH, Gurdon JB: Nuclear exclusion of Smad2 is a mechanism leading to loss of
for the ErbB receptors using protein microarrays. Nature 439:168, 2006. competence. Nat Cell Biol 4:519, 2002.
86. Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 270:14843, 111. Wang Q, Miyakawa Y, Fox N, et al: Interferon-alpha directly represses megakaryopoie-
1995. sis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1.
87. Whitmarsh AJ, Davis RJ: Structural organization of MAP-kinase signaling modules by Blood 96:2093, 2000.
scaffold proteins in yeast and mammals. Trends Biochem Sci 23:481, 1998. 112. Singer SJ, Nicolson GL: The fluid mosaic model of the structure of cell membranes.
88. Lee CM, Onesime D, Reddy CD, et al: JLP: A scaffolding protein that tethers JNK/ Science 175:720, 1972.
p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A 113. Brown DA, Rose JK: Sorting of GPI-anchored proteins to glycolipid-enriched mem-
99:14189, 2002. brane subdomains during transport to the apical cell surface. Cell 68:533, 1992.
89. Soond SM, Terry JL, Colbert JD, et al: TRUSS, a novel tumor necrosis factor receptor 1 114. Viola A, Schroeder S, Sakakibara Y, et al: T lymphocyte costimulation mediated by
scaffolding protein that mediates activation of the transcription factor NF-kappaB. Mol reorganization of membrane microdomains. Science 283:680, 1999.
Cell Biol 23:8334, 2003. 115. Sonnino S, Prinetti A: Membrane domains and the “lipid raft” concept. Curr Med Chem
90. Chiu CW, Dalton M, Ishiai M, et al: BLNK: Molecular scaffolding through “cis”-medi- 20:4, 2013.
ated organization of signaling proteins. EMBO J 21:6461, 2002. 116. Hemler ME: Tetraspanin proteins mediate cellular penetration, invasion, and fusion
91. Besson A, Wilson TL, Yong VW: The anchoring protein RACK1 links protein kinase events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol
Cepsilon to integrin beta chains. Requirements for adhesion and motility. J Biol Chem 19:397, 2003.
277:22073, 2002. 117. Cook GA, Longhurst CM, Grgurevich S, et al: Identification of CD9 extracellular
92. Yee NS, Langen H, Besmer P: Mechanism of kit ligand, phorbol ester, and calcium- domains important in regulation of CHO cell adhesion to fibronectin and fibronectin
induced down-regulation of c-kit receptors in mast cells. J Biol Chem 268:14189, 1993. pericellular matrix assembly. Blood 100:4502, 2002.
93. Vieira AV, Lamaze C, Schmid SL: Control of EGF receptor signaling by clathrin- 118. Miyazaki T, Muller U, Campbell KS: Normal development but differentially altered pro-
mediated endocytosis. Science 274:2086, 1996. liferative responses of lymphocytes in mice lacking CD81. EMBO J 16:4217, 1997.
94. Broudy VC, Lin NL, Liles WC, et al: Signaling via Src family kinases is required for 119. Clay D, Rubinstein E, Mishal Z, et al: CD9 and megakaryocyte differentiation. Blood
normal internalization of the receptor c-Kit. Blood 94:1979, 1999. 97:1982, 2001.
95. Dahlen DD, Broudy VC, Drachman JG: Internalization of the thrombopoietin receptor 120. Anzai N, Lee Y, Youn BS, et al: C-kit associated with the transmembrane 4 superfamily
is regulated by 2 cytoplasmic motifs. Blood 102:102, 2003. proteins constitutes a functionally distinct subunit in human hematopoietic progeni-
96. Hitchcock I, Chen M, Fox NE, Kaushansky K: YRRL motifs in the cytoplasmic domain tors. Blood 99:4413, 2002.
of the thrombopoietin receptor regulate receptor internalization and degradation. 121. Skubitz KM, Campbell KD, Iida J, et al: CD63 associates with tyrosine kinase activ-
Blood 112:2222, 2008 ity and CD11/CD18, and transmits an activation signal in neutrophils. J Immunol
97. Zhang J, Somani AK, Siminovitch KA: Roles of the SHP-1 tyrosine phosphatase in the 157:3617, 1996.
negative regulation of cell signalling. Semin Immunol 12:361, 2000. 122. Kurita-Taniguchi M, Hazeki K, Murabayashi N, et al: Molecular assembly of CD46 with
98. Tsui HW, Siminovitch KA, De Souza L, et al: Motheaten and viable motheaten mice CD9, alpha3-beta1 integrin and protein tyrosine phosphatase SHP-1 in human macro-
have mutations in the haematopoietic cell phosphatase gene. Nat Genet 4:124, 1993. phages through differentiation by GMCSF. Mol Immunol 38:689, 2002.

Kaushansky_chapter 17_p0247-0256.indd 255 9/17/15 5:45 PM